CAT-152 Trabeculectomy Study.
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D044383:Black People / Q000208:ethnology; D003228:Conjunctiva / Q000473:pathology; D003229:Conjunctival Diseases / Q000517:prevention & control*; D005355:Fibrosis / Q000517:prevention & control; D005901:Glaucoma / Q000208:ethnology / Q000601:surgery*; D006801:Humans; D007267:Injections; D007429:Intraocular Pressure; D015337:Multicenter Studies as Topic; D016032:Randomized Controlled Trials as Topic; D014129:Trabecular Meshwork / Q000601:surgery*; D014130:Trabeculectomy; D016896:Treatment Outcome; D044465:White People / Q000208:ethnology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C475848:Lerdelimumab